Tagged lateral-flow-test

Senzo Secures an Additional $1.8m Investment for Its Novel Rapid Home-Test Diagnostic Platform
Press Release

Senzo Secures an Additional $1.8m Investment for Its Novel Rapid Home-Test Diagnostic Platform

 Senzo Health Limited (London, UK) ("Senzo"), a life sciences company developing high-accuracy, low-cost, point-of-care diagnostic technologies, this week announced an additional $1.8m investment for its breakthrough Amplified Lateral Flow (ALF) test technology, advancing its mission to bring high-quality, affordable tests into the home. Read More
Senzo Secures Additional $1.9MM Equity Funding for Its PCR-Accurate Lateral Flow Test
Press Release

Senzo Secures Additional $1.9MM Equity Funding for Its PCR-Accurate Lateral Flow Test

 The funding, led by existing investors BioAdvance and Wellness Coaches, follows additional 3rd party studies by University College London and LateralDx, confirming that Senzo's Amplified Lateral Flow (ALF) platform returned greater than 98% accuracy against PCR, including in low viral-load samples Read More
Senzo Announces ISO 13485:2016 Certification for Its Quality Management System
Press Release

Senzo Announces ISO 13485:2016 Certification for Its Quality Management System

 The ISO 13485:2016 certification confirms Senzo as a leading provider of in vitro diagnostic device development, as it brings its Amplified Lateral Flow (ALF) technology to market Read More
Press Release

BBInternational Join EMD Millipore and Kinematic for San Diego Seminar on Lateral Flow

 BBI join EMD Millipore and Kinematic to educate in the field of lateral flow and ensuring faster, higher performing and more robust systems. Read More